Angelika Eggert

Full Professor of Pediatrics & Director

Charité - Universitätsmedizin Berlin

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Jörg Fallmann

Leipzig University

GERMANY

View details

Tobias Herold

University Hospital, LMU Munich

GERMANY

View details

Michael Hummel

Charité - Universitätsmedizin Berlin

GERMANY

View details

Jennifer Kirwan

Head of Platform

Max Delbrück Center for Molecular Medicine

GERMANY

View details

Hedwig E. Deubzer

GERMANY

View details

Holger Lode

Professor and Chair of Pediatrics

University Medicine Greifswald

GERMANY

View details

Anja Kühl

Head & PI /Ph.D.

Charité - Universitätsmedizin Berlin

GERMANY

View details

Raphaela Fritsche

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

View details

Victor Bardinet

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

View details

Johannes Hubertus Schulte

Head of Pediatric Stem Cell Transplantation; Professor of Pediatric Oncology Research

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

View details

Georg Seifert

Charité - Universitätsmedizin Berlin

GERMANY

View details

Michael Launspach

Charité

GERMANY

View details

Boris Hadaschik

Universität Duisburg-Essen

GERMANY

View details

Peter Lang

GERMANY

View details

Aleksandra Wieczorek

Jagiellonian University Medical College

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Angelika Eggert

Research Interests

Explore related searches

Contact this professor

Articles (16)

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models

Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer.

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.

Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease.

X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform

Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy

Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN.

Parallel sequencing of extrachromosomal circular DNAs and transcriptomes in single cancer cells.

Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse

Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients.

Mutational topography reflects clinical neuroblastoma heterogeneity.

Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model.

Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry

Collaborators (15)

Jörg Fallmann

Tobias Herold

Michael Hummel

Jennifer Kirwan

Hedwig E. Deubzer

Holger Lode

Anja Kühl

Raphaela Fritsche

Victor Bardinet

Johannes Hubertus Schulte

Georg Seifert

Michael Launspach

Boris Hadaschik

Peter Lang

Aleksandra Wieczorek

Make your next move.